Misonix to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Summary

Misonix, Inc. (NASDAQ: MSON) announced participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2 and 3, 2020. CEO Stavros Vizirgianakis and CFO Joe Dwyer will engage in one-on-one meetings with registered investors during the event. Misonix specializes in minimally invasive ultrasonic medical devices and regenerative products that enhance clinical results. Their offerings include products for surgery and wound care, aimed at improving outcomes in various medical fields.

FARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer will be participating in the Piper Sandler 32^nd Annual Virtual Healthcare Conference on Wednesday, December 2 and Thursday, December 3, 2020. Management will be available to host one-on-one meetings with investors who are registered to attend the conference throughout the day.

For more information about the conferences or to schedule a virtual one-on-one meeting with management, please contact your conference representative. Alternatively, please contact Misonix’s investor relations firm, JCIR, at mson@jcir.com.

About Misonix, Inc.
Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company's web site at www.misonix.com.

Contact:
Joe Dwyer Chief Financial Officer Misonix, Inc. 631-927-9113	Norberto Aja, Jennifer Neuman JCIR 212-835-8500 or mson@jcir.com

FAQ

When is the Piper Sandler 32nd Annual Virtual Healthcare Conference for Misonix (MSON)?

The conference will take place on December 2 and 3, 2020.

Who from Misonix will be participating in the virtual conference?

CEO Stavros Vizirgianakis and CFO Joe Dwyer will participate.

How can investors schedule one-on-one meetings with Misonix management during the conference?

Investors can contact their conference representative or reach out to Misonix’s investor relations firm, JCIR.

What types of products does Misonix (MSON) provide?

Misonix offers minimally invasive therapeutic ultrasonic medical devices and regenerative products for surgical and wound care.

What is Misonix known for in the medical device industry?

Misonix is known for its innovations in ultrasonic medical devices used for precise surgery and effective wound treatment.